|
Characteristic
|
Control cohort
|
Cancer cohort
|
|---|
|
n = 136
|
n = 77
|
|---|
|
Age (years)
|
|
Mean (range)
|
50.4 (23–88)
|
66.4 (47–86)
|
|
Sex, no. (%)
|
|
Male
|
72 (52.9)
|
65 (84.4)
|
|
Female
|
64 (47.1)
|
12 (15.6)
|
|
Ethnicity, no. (%)
|
|
Caucasian
|
100 (73.5)
|
74 (96.1)
|
|
Asian
|
22 (16.2)
|
2 (2.6)
|
|
African-American
|
3 (2.2)
|
0 (0)
|
|
Hispanic
|
1 (0.7)
|
1 (1.3)
|
|
Other
|
0 (0)
|
0 (0)
|
|
Not available
|
10 (7.4)
|
0 (0)
|
|
Tumor type, no. (%)
|
|
NMIBC, TCC
|
n.a
|
66 (85.7)
|
|
MIBC, TCC
|
n.a
|
10 (13.0)
|
|
AC
|
n.a
|
1 (1.3)
|
|
SCC
|
n.a
|
0 (0)
|
|
Tumor grade, no. (%)
|
|
Low grade
|
n.a
|
10 (13.0)
|
|
High grade
|
n.a
|
51 (66.2)
|
|
Not Available
|
n.a
|
16 (20.8)
|
- NMIBC non-muscle invasive bladder cancer, MIBC muscle invasive bladder cancer, TCC transitional cell carcinoma, AC adenocarcinoma, SCC squamous cell carcinoma, n.a. not applicable
